REG - Venture Life Group - Reporting Update

Venture LifeAnnouncement

19/04/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220419:nRSS4697Ia&default-theme=true

RNS Number : 4697I  Venture Life Group PLC  19 April 2022

 

VENTURE LIFE GROUP PLC

("Venture Life" "VLG" or the "Group")

Reporting Update

 

 

Further to the announcement on 23 March 2022 Venture Life provides an update
on the timing of the announcement of its results for the year ended 31
December 2021.

The Company's auditors continue to experience resourcing issues and as such
have advised that additional time is required to finalise their procedures.
Accordingly the Company now expects to be able to announce its audited results
for the year ended 31 December in early May.

The Company reiterates its guidance stated in its trading update on 31st
January 2022:

·    Revenue of £32.6 million for the FY21(2020: £30.1 million), up 8%
on the prior year;

·    Revenue in the second half of the year was £18.7 million, an
increase of 35% over the revenues in the first half of the year (£13.9
million);

·    Adjusted EBITDA in line with market expectations;

·    Momentum building in the business post acquisitions demonstrated by
Q4 revenue 59% above that in Q3; and

·    Net debt of £3.2m pre-IFRS16 (£7.3m IFRS16) reflecting a phasing
effect on working capital as a result of higher receivables following strong
Q4 revenue.

 

For further information, please contact:

 

 Venture Life Group PLC                              +44 (0) 1344 578004
 Jerry Randall, Chief Executive Officer

 Daniel Wells, Chief Financial Officer

 Cenkos Securities plc (Nomad and Joint Broker)      +44 (0) 20 7397 8900
 Michael Johnson/Russell Kerr (Sales)

 Stephen Keys/Camilla Hume (Corporate Finance)

 Singer Capital markets (Joint Broker)               +44 (0) 20 7496 3000
 Jonathan Dighe (Sales)

 Shaun Dobson/Alaina Wong (Corporate Finance)

About Venture Life (www.venture-life.com (http://www.venture-life.com/) )

Venture Life is an international consumer self-care company focused on
developing, manufacturing and commercialising products for the global
self-care market. With operations in the UK, Italy, The Netherlands and
Sweden, the Group's product portfolio includes some key products such as the
UltraDEX and Dentyl oral care product ranges, the Balance Activ range in the
area of women's intimate healthcare, the Lift and Glucogel product ranges for
hypoglycaemia, products for fungal infections and proctology, and
dermo-cosmetics for addressing the signs of ageing. Its products are sold in
over 90 countries worldwide.

The products, which are typically recommended by pharmacists or healthcare
practitioners, are available primarily through pharmacies and grocery
multiples. In the UK and The Netherlands these are supplied direct by the
company to retailers, elsewhere they are supplied by the Group's international
distribution partners.

Through its two Development & Manufacturing operations in Italy and
Sweden, the Group also provides development and manufacturing services to
companies in the medical devices and cosmetic sectors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STRZZLFFLZLFBBL